Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation
Small Science · 2026-01 · 6 (1)
DOI: 10.1002/smsc.202500481 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Science, online erschienen am 19.11.2025. Verfasst von Yiyin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Soochow University Soochow University Suzhou 215000 China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Natural Science Foundation of China.
Abstract (Originalsprache)
Regulatory T cells (Tregs) orchestrate immune tolerance, protecting against autoimmunity and promoting transplant tolerance, yet they can also facilitate tumor immune evasion. Advances in nanotechnology now permit high‐precision manipulation of Treg biology. Tailored polymeric, lipid‐based, inorganic, and biomimetic nanoparticles can be engineered to deliver antigens, cytokines, small‐molecule drugs, antibodies, or nucleic acids that selectively expand or stabilize Tregs for tolerogenic therapy; the same design principles can be inverted to inhibit or deplete intratumoral Tregs, thereby restoring effective antitumor immunity. Beyond intentional therapies, the review also explores unintended immunological consequences of nanoparticles, such as inadvertent induction of Tregs or broader immunosuppressive responses, and how Tregs can conversely limit the efficacy of nanoparticle‐based vaccines or cancer nanotherapies. Outstanding challenges related to targeting efficiency, safety, manufacturability, and combinatorial therapeutic strategies are outlined, and prospective avenues for future investigation are highlighted. Collectively, emerging data position Treg‐focused nanomedicine as a versatile and clinically relevant toolkit for restoring or unleashing immunity across autoimmunity, transplantation, and oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Soochow University Soochow University Suzhou 215000 China.
- National Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Soochow University Suzhou 215000 China.
- Institute of Blood and Marrow Transplantation Collaborative Innovation Center of Hematology Soochow University Suzhou 215000 China.
- Taizhou Second People's Hospital Affiliated to Yangzhou University Taizhou 225300 China.
- Xinghua People's Hospital Affiliated to Yangzhou University Taizhou 225700 China.
- Department of Anesthesiology The First People's Hospital of Changzhou Changzhou 213000 China.
ORCID-Profile: Yiyin Chen, Yan Chen, Bruce R Blazar, Yang Xu, Yunjie Lu
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Huang, H., Wang, X., Yu, X., Huang, Z., Jin, Z., Chen, C., Chen, Y., Blazar, B. R., Xu, Y., & Lu, Y. (2026). Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation. Small Science, 6(1). https://doi.org/10.1002/smsc.202500481
Vancouver
Chen Y, Huang H, Wang X, Yu X, Huang Z, Jin Z, et al. Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation. Small Science. 2026;6(1). doi:10.1002/smsc.202500481
BibTeX
@article{Chen2026,
author = {Chen, Yiyin and Huang, Haibo and Wang, Xiang and Yu, Xinghao and Huang, Ziyan and Jin, Zhou and Chen, Chen and Chen, Yan and Blazar, Bruce R and Xu, Yang and Lu, Yunjie},
title = {Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation},
journal = {Small Science},
year = {2026},
volume = {6},
number = {1},
doi = {10.1002/smsc.202500481}
}
EUVIMED